Rekvina Laboratories Limited (BOM:526075)
India · Delayed Price · Currency is INR 40.77
-0.83 (-2.00%)
At close: May 6, 2026
Rekvina Laboratories Market Cap
Rekvina Laboratories has a market cap or net worth of 240.88 million as of May 7, 2026. Its market cap has increased by 718.85% in one year.
Market Cap
240.88M
Enterprise Value
248.98M
Revenue
5.42M
Ranking
n/a
PE Ratio
n/a
Stock Price
40.77
Market Cap Chart
Since July 26, 2013, Rekvina Laboratories's market cap has decreased from 443.60M to 240.88M, a decrease of -45.70%. That is a compound annual growth rate of -4.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2026 | 240.88M | 788.00% |
| Dec 13, 2021 | 27.13M | 4.65% |
| Dec 26, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Welcure Drugs and Pharmaceuticals | 358.42M |
| ANG Lifesciences India | 357.54M |
| Murae Organisor | 353.20M |
| Walpar Nutritions | 347.45M |
| JFL Life Sciences | 308.51M |
| Deccan Health Care | 306.17M |
| Gujarat Terce Laboratories | 295.45M |
| Hamps Bio | 223.72M |